Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

DATA ANALYSIS

Big data: the opportunity to think outside the discipline

Nature Reviews Rheumatology volume 15, pages 639–640 (2019)Cite this article

Subjects

EULAR has published points to consider for the use of big data in rheumatology research that open up discussions and debates that are necessary and important, but are they missing the opportunities presented by cross-discipline collaboration to expand our perspective of disease beyond what is clinically visible?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gossec, L. et al. EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2019-215694 (2019).

    Article  PubMed  Google Scholar 

  2. Tedeschi, S. K. et al. Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration. Arthritis Care Res. 4, 571–581 (2016).

    Google Scholar 

  3. ELIXIR. ELIXIR Data Platform. Elixir-europe.org https://www.elixir-europe.org/platforms/data (2017).

  4. Kinkorová, J. & Topolcˇan, O. Biobanks in Horizon 2020: sustainability and attractive perspectives. EPMA J. 9, 345–353 (2018).

    Article  Google Scholar 

  5. Barturen, G. et al. Moving towards a molecular taxonomy of autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 14, 75–93 (2018).

    Article  CAS  Google Scholar 

  6. Innovative Medicines Initiative. Immune diseases and machine learning feature in new IMI Call for proposals. Imi.europa.eu https://www.imi.europa.eu/news-events/press-releases/immune-diseases-and-machine-learning-feature-new-imi-call-proposals (2018).

Download references

Acknowledgements

The work of the author has been supported by the Fundación Pública Andaluza Progreso y Salud.

Author information

Authors and Affiliations

  1. GENYO. Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

    Marta E. Alarcón-Riquelme

Authors
  1. Marta E. Alarcón-Riquelme
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta E. Alarcón-Riquelme.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alarcón-Riquelme, M.E. Big data: the opportunity to think outside the discipline. Nat Rev Rheumatol 15, 639–640 (2019). https://doi.org/10.1038/s41584-019-0292-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-019-0292-9

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing